These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1152601)

  • 21. Opioid receptor agonist potencies of morphine and morphine-6-glucuronide in the guinea-pig ileum.
    Schmidt N; Brune K; Geisslinger G
    Eur J Pharmacol; 1994 Apr; 255(1-3):245-7. PubMed ID: 8026550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some thoughts on the significance of enkephalin, the endogenous ligand.
    Kosterlitz HW; Hughes J
    Life Sci; 1975 Jul; 17(1):91-6. PubMed ID: 806763
    [No Abstract]   [Full Text] [Related]  

  • 23. The purification of a kininogen from human plasma.
    Brocklehurst WE; Mawer GE
    Br J Pharmacol Chemother; 1966 Aug; 27(2):256-76. PubMed ID: 5967365
    [No Abstract]   [Full Text] [Related]  

  • 24. Enhancement of etorphine brain concentrations and changes in etorphine-naloxone pA2 values in morphine-pretreated mice.
    Lange DG; Roerig SC; Fujimoto JM; Wang RI
    Biochem Pharmacol; 1981 Jan; 30(2):147-55. PubMed ID: 7236304
    [No Abstract]   [Full Text] [Related]  

  • 25. Hormonal and immunological properties of insulin fragments. II. Products obtained by enzymatic hydrolysis.
    Surmaczynska B; Metz R; Barrett R; Lucena G
    Endocrinology; 1969 Sep; 85(3):577-81. PubMed ID: 5793036
    [No Abstract]   [Full Text] [Related]  

  • 26. Coriticotrophin-like intermediate lobe peptide--a new pituitary and tumour peptide.
    Scott AP; Bennett HP; Lowry PJ; McMartin C; Ratcliffe JG
    J Endocrinol; 1972 Nov; 55(2):xxxvi-xxxv. PubMed ID: 4344243
    [No Abstract]   [Full Text] [Related]  

  • 27. The structure-action relationship and kinetics of some naloxone and naltrexone derivatives.
    Vizi ES; Foldes FF; Rich J; Knoll J
    Pharmacology; 1976; 14(1):76-85. PubMed ID: 959310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.
    Valentino RJ; Katz JL; Medzihradsky F; Woods JH
    Life Sci; 1983 Jun; 32(25):2887-96. PubMed ID: 6304445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of endorphins (peptides with morphine-like pharmacological activity) in pituitary.
    Ross M; Dingledine R; Cox BM; Goldstein A
    Brain Res; 1977 Apr; 124(3):523-32. PubMed ID: 851863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some pharmacological properties of a newly synthesized morphine derivative, (-)-6 beta-acetylthiomorphine.
    Takayanagi I; Konno F; Goromaru N; Koike K; Kanematsu K; Fujii I; Togame H
    Arch Int Pharmacodyn Ther; 1988; 294():71-84. PubMed ID: 3069065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey.
    Hutchinson M; Kosterlitz HW; Leslie FM; Waterfield AA
    Br J Pharmacol; 1975 Dec; 55(4):541-6. PubMed ID: 2359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of development of tolerance to injected morphine by guinea pig ileum.
    Ehrenpreis S; Greenberg J; Comaty JE
    Life Sci; 1975 Jul; 17(1):49-54. PubMed ID: 1143010
    [No Abstract]   [Full Text] [Related]  

  • 33. Absence of biochemical and pharmacological effects of the trypsinogen activation peptide.
    Kay J; Kassell B; Friedman HL
    J Med Chem; 1971 Nov; 14(11):1124-6. PubMed ID: 5115219
    [No Abstract]   [Full Text] [Related]  

  • 34. Naloxone-induced facilitation of contractions, spontaneous activity and tolerance to morphine in ileum of morphine-dependent guinea-pigs.
    Van Nueten JM; Lal H
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):378-82. PubMed ID: 4859425
    [No Abstract]   [Full Text] [Related]  

  • 35. Intestinal effect of morphine 6-glucuronide: in vivo and in vitro characterization.
    Massi P; Giagnoni G; Basilico L; Gori E; Rubino T; Parolaro D
    Eur J Pharmacol; 1994 Mar; 253(3):269-74. PubMed ID: 8200420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine dependence and diabetes. II. Alterations of normorphine potency in the guinea-pig ileum and mouse vas deferens and of ileal morphine dependence by changes in glucose concentration.
    Shook JE; Kachur JF; Brase DA; Dewey WL
    J Pharmacol Exp Ther; 1986 Jun; 237(3):848-52. PubMed ID: 3712282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porcine pituitary peptides with opiate-like activity: partial purification and effects in the rat after intraventricular injection.
    Teschemacher H; Bläsig J; Kromer W
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep; 294(3):293-5. PubMed ID: 1034219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and properties of two biologically active fragments from limited tryptic hydrolysis of bovine and ovine pituitary growth hormones.
    Gráf L; Li CH
    Biochemistry; 1974 Dec; 13(26):5408-15. PubMed ID: 4433527
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation of a novel endogenous opiate analgesic from human blood.
    Pert CB; Pert A; Tallman JF
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2226-30. PubMed ID: 1065871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine produces release of substance P-like immunoreactivity from guinea-pig central nervous system.
    Chahl LA
    Neurosci Lett; 1990 Oct; 118(1):88-90. PubMed ID: 1701871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.